SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-037644
Filing Date
2024-03-28
Accepted
2024-03-28 08:40:41
Documents
96
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K atra-20231231.htm   iXBRL 10-K 3140371
2 EX-10.29 atra-ex10_29.htm EX-10.29 26966
3 EX-10.30 atra-ex10_30.htm EX-10.30 29475
4 EX-10.31 atra-ex10_31.htm EX-10.31 723614
5 EX-21.1 atra-ex21_1.htm EX-21.1 6131
6 EX-23.1 atra-ex23_1.htm EX-23.1 3158
7 EX-31.1 atra-ex31_1.htm EX-31.1 13789
8 EX-31.2 atra-ex31_2.htm EX-31.2 13670
9 EX-32.1 atra-ex32_1.htm EX-32.1 11504
10 EX-97.1 atra-ex97_1.htm EX-97.1 37375
11 GRAPHIC img120931721_0.jpg GRAPHIC 586222
  Complete submission text file 0000950170-24-037644.txt   14473722

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT atra-20231231.xsd EX-101.SCH 1751766
100 EXTRACTED XBRL INSTANCE DOCUMENT atra-20231231_htm.xml XML 2054588
Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320 805-623-4244
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36548 | Film No.: 24793778
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)